Zobrazeno 1 - 10
of 193
pro vyhledávání: '"G M Felker"'
Autor:
I. E. Beldhuis, J. M. ter Maaten, S. M. Figarska, K. Damman, P. S. Pang, B. Greenberg, B. A. Davison, G. Cotter, T. Severin, C. Gimpelewicz, G. M. Felker, G. Filippatos, J. R. Teerlink, M. Metra, A. A. Voors
Publikováno v:
Clinical Research in Cardiology.
Background We aimed to study whether improvement in renal function by serelaxin in patients who were hospitalized for acute heart failure (HF) might explain any potential effect on clinical outcomes. Methods We included 6318 patients from the RELAXin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db47d5a734efa2dca174fb593b692e5e
https://doi.org/10.1007/s00392-022-02144-6
https://doi.org/10.1007/s00392-022-02144-6
Autor:
S Greene, J A Spertus, W Tang, A Kang, Y Zhong, M Myers, S Shen, J Jiang, X Liu, D R Steffen, M Viola, G M Felker
Publikováno v:
European Heart Journal. 43
Introduction Recent clinical trials of heart failure with preserved ejection fraction (HFpEF) have observed varying patient profiles by ejection fraction (EF), with attenuation of treatment benefits as EF increases. In routine clinical practice, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc7a7ea6481a0fce2e2b0886ef333ed2
https://doi.org/10.1093/eurheartj/ehac544.863
https://doi.org/10.1093/eurheartj/ehac544.863
Publikováno v:
European Heart Journal. 43
Introduction Severe tricuspid valve regurgitation (TR) is associated with increased 1-year morbidity and mortality. Characterization by valve etiology (primary, secondary, and lead-associated), a classification borrowed from mitral valve disease, has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74b763dde7b57e1435619a73745d10ff
https://doi.org/10.1093/eurheartj/ehac544.1656
https://doi.org/10.1093/eurheartj/ehac544.1656
Autor:
G. M Felker, Adrian F. Hernandez, Adrian Coles, Margaret M. Redfield, S J McNulty, Greg D. Lewis, J G Kelly, Aaron D. Jones, Marat Fudim
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::362f29635d99299ac378da0b671643d7
https://doi.org/10.1093/eurheartj/ehy564.p884
https://doi.org/10.1093/eurheartj/ehy564.p884
Autor:
Jennifer B. Green, Jingjing Wu, Abhinav Sharma, G. M Felker, Roland A. Matsouaka, Sana M. Al-Khatib, Justin A. Ezekowitz, Paul A. Heidenreich, Adam D. DeVore, Adrian F. Hernandez, Gregg C. Fonarow, Jagmeet P. Singh
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 11
Introduction: Patients with diabetes mellitus (DM) and heart failure with reduced ejection fraction (HFrEF) are at increased risk of sudden death. However, given the burden of competing causes of death in patients with DM, therapies to reduce the ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c638da1aed707cabba2813dff06e1d1
https://doi.org/10.1161/circoutcomes.11.suppl_1.122
https://doi.org/10.1161/circoutcomes.11.suppl_1.122
Autor:
Di X; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China., Li Y; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China., Wei J; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China., Li T; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China., Liao B; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Dec 12, pp. e2410416. Date of Electronic Publication: 2024 Dec 12.
Autor:
Susanna R. Stevens, G. M Felker, Bradley A Bart, Horng H. Chen, Steven R Goldsmith, Hiroyuki Takahama, Margaret M. Redfield, Virginia B Hebl
Publikováno v:
Circulation. 130
Background: The Acute Decompensated Heart Failure National Registry (ADHERE) risk levels are a validated tool to assess the risk of in-hospital mortality in patients with acute decompensated heart failure (ADHF). The objective of this study is to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7085e086e1d998a6a11d2c416f88ff66
https://doi.org/10.1161/circ.130.suppl_2.16958
https://doi.org/10.1161/circ.130.suppl_2.16958
Autor:
William E Kraus, Mark P Donahue, Svati H Shah, David J Whellan, Anne Hellkamp, Christopher M O’Connor, G. M Felker
Publikováno v:
Circulation. 127
Blood-borne small metabolic intermediates have been associated with disease severity and major adverse coronary events (MACE), including mortality alone, in a cardiovascular disease population. Specifically, short chain dicarboxylacylcarnitines (SCDC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42140a6174229b10ba7d67cf9f275fc3
https://doi.org/10.1161/circ.127.suppl_12.ap272
https://doi.org/10.1161/circ.127.suppl_12.ap272
Autor:
G. M. Felker, H. Q. Sinclair
Publikováno v:
MD Conference Express. 10:16-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08602c9cc6ffad34aaab54eb818a617b
https://doi.org/10.1177/155989771002009
https://doi.org/10.1177/155989771002009
Autor:
Kenneth L. Baughman, Richard E. Thompson, David L. Howard, D E Clemetson, G M Felker, Joshua M. Hare, Edward K. Kasper, Ralph H. Hruban
Publikováno v:
The New England journal of medicine. 342(15)
Background Previous studies of the prognosis of patients with heart failure due to cardiomyopathy categorized patients according to whether they had ischemic or nonischemic disease. The prognostic value of identifying more specific underlying causes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4649adfd02b4cbdd6b425d6c4815f581
https://pubmed.ncbi.nlm.nih.gov/10760314
https://pubmed.ncbi.nlm.nih.gov/10760314